Complication and lung function impairment prediction using perfusion and computed tomography air trapping (CLIPPCAIR): protocol for the development and validation of a novel multivariable model for the prediction of post-resection lung function

Carey Meredith Suehs, Laurence Solovei, Kheira Hireche, Isabelle Vachier, Denis Mariano Goulart, Lucie Gamon, Jérémy Charriot, Isabelle Serre, Nicolas Molinari, Arnaud Bourdin, Sébastien Bommart, Carey Meredith Suehs, Laurence Solovei, Kheira Hireche, Isabelle Vachier, Denis Mariano Goulart, Lucie Gamon, Jérémy Charriot, Isabelle Serre, Nicolas Molinari, Arnaud Bourdin, Sébastien Bommart

Abstract

Background: Recent advancements in computed tomography (CT) scanning and post processing have provided new means of assessing factors affecting respiratory function. For lung cancer patients requiring resection, and especially those with respiratory comorbidities such as chronic obstructive pulmonary disease (COPD), the ability to predict post-operative lung function is a crucial step in the lung cancer operability assessment. The primary objective of the CLIPPCAIR study is to use novel CT data to develop and validate an algorithm for the prediction of lung function remaining after pneumectomy/lobectomy.

Methods: Two sequential cohorts of non-small cell lung cancer patients requiring a pre-resection CT scan will be recruited at the Montpellier University Hospital, France: a test population (N=60) on which predictive models will be developed, and a further model validation population (N=100). Enrolment will occur during routine pre-surgical consults and follow-up visits will occur 1 and 6 months after pneumectomy/lobectomy. The primary outcome to be predicted is forced expiratory volume in 1 second (FEV1) six months after lung resection. The baseline CT variables that will be used to develop the primary multivariable regression model are: expiratory to inspiratory ratios of mean lung density (MLDe/i for the total lung and resected volume), the percentage of voxels attenuating at less than ‒950 HU (PVOX‒950 for the total lung and resected volume) and the ratio of iodine concentrations for the resected volume over that of the total lung. The correlation between predicted and real values will be compared to (and is expected to improve upon) that of previously published methods. Secondary analyses will include the prediction of transfer factor for carbon monoxide (TLCO) and complications in a similar fashion. The option to explore further variables as predictors of post-resection lung function or complications is kept open.

Discussion: Current methods for estimating post-resection lung function are imperfect and can add assessments (such as scintigraphy) to the pre-surgical workup. By using CT imaging data in a novel fashion, the results of the CLIPPCAIR study may not only improve such estimates, it may also simplify patient pathways.

Trial registration: Clinicaltrials.gov (NCT03885765).

Keywords: Non-small cell lung cancer; lobectomy; mean lung density; pneumectomy; respiratory function.

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/atm-21-214). Dr. Suehs reports grants from Astra Zeneca, outside the submitted work. Dr. Molinari reports personal fees from Astra Zeneca, grants from GSK, outside the submitted work. Dr. Bourdin reports grants, personal fees, non-financial support and other (Ad Board; participation in congress; investigator) from Astra Zeneca, grants, personal fees and other (Ad Board; participation in congress; investigator) from GSK, grants, personal fees, non-financial support and other (Ad Board; participation in congress; investigator) from Boeringher Ingelheim, personal fees, non-financial support and other (Ad Board; participation in congress; investigator) from Novartis, personal fees and other (Ad Board; investigator) from Teva, personal fees and other (Ad Board; investigator) from Regeneron, personal fees, non-financial support and other (Ad Board; participation in congress; investigator) from Chiesi Farmaceuticals, personal fees, non-financial support and other (Ad Board; participation in congress; investigator) from Actelion, other (Investigator) from Gilead, personal fees, non-financial support and other (Ad Board; investigator) from Roche, outside the submitted work.

2021 Annals of Translational Medicine. All rights reserved.

Figures

Figure 1
Figure 1
Separate “test” and “validation” groups will be recruited.
Figure 2
Figure 2
Computed tomography (CT) scan attenuation forms a gradient from less dense (darker grey) to more dense (lighter grey). Emphysema is visualized on inspiratory CT as relatively darker spots or areas, as seen on Panel A. The proportion of voxels attenuating below a given threshold (PVOX-950:

Figure 3

The visits required during the…

Figure 3

The visits required during the study correspond to usual care for the study…

Figure 3
The visits required during the study correspond to usual care for the study population. Preliminary patient screening is discussed during weekly multidisciplinary team (MDT) meetings, and enrolment takes place during routine visits required during the pre-surgical workup to lung resection. The latter work-up requires that spirometry, a thoracic computed tomography (CT) scan and lung scintigraphy (only for high-risk patients) be performed within 30 days of surgery. Additional data will be acquired during routing follow-up visits at 1- and 6-months following surgery.
Figure 3
Figure 3
The visits required during the study correspond to usual care for the study population. Preliminary patient screening is discussed during weekly multidisciplinary team (MDT) meetings, and enrolment takes place during routine visits required during the pre-surgical workup to lung resection. The latter work-up requires that spirometry, a thoracic computed tomography (CT) scan and lung scintigraphy (only for high-risk patients) be performed within 30 days of surgery. Additional data will be acquired during routing follow-up visits at 1- and 6-months following surgery.

References

    1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. 10.3322/caac.21492
    1. Fidler-Benaoudia MM, Torre LA, Bray F, et al. Lung cancer incidence in young women vs. young men: A systematic analysis in 40 countries. Int J Cancer 2020;147:811-9. 10.1002/ijc.32809
    1. Mathew B, Nag S, Agrawal A, et al. Comparison of predicted postoperative forced expiratory volume in the first second (FEV1) using lung perfusion scintigraphy with observed forced expiratory volume in the first second (FEV1) post lung resection. World J Nucl Med 2020;19:131-6. 10.4103/wjnm.WJNM_59_19
    1. Pujol JL, Quantin X. Time to diagnosis of lung cancer: technical and pyschological factors that slow down diagnostic and treatment timelines. J Thorac Oncol 2009;4:1192-4. 10.1097/JTO.0b013e3181b88045
    1. Nadpara P, Madhavan SS, Tworek C. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study. Cancer Epidemiol 2015;39:1136-44. 10.1016/j.canep.2015.06.005
    1. Jamadar DA, Kazerooni EA, Martinez FJ, et al. Semi-quantitative ventilation/perfusion scintigraphy and single-photon emission tomography for evaluation of lung volume reduction surgery candidates: description and prediction of clinical outcome. Eur J Nucl Med 1999;26:734-42. 10.1007/s002590050444
    1. Thurnheer R, Engel H, Weder W, et al. Role of lung perfusion scintigraphy in relation to chest computed tomography and pulmonary function in the evaluation of candidates for lung volume reduction surgery. Am J Respir Crit Care Med 1999;159:301-10. 10.1164/ajrccm.159.1.9711030
    1. Bolliger CT, Gückel C, Engel H, et al. Prediction of functional reserves after lung resection: comparison between quantitative computed tomography, scintigraphy, and anatomy. Respiration 2002;69:482-9. 10.1159/000066474
    1. Wu MT, Chang JM, Chiang AA, et al. Use of quantitative CT to predict postoperative lung function in patients with lung cancer. Radiology 1994;191:257-62. 10.1148/radiology.191.1.8134584
    1. Wu MT, Pan HB, Chiang AA, et al. Prediction of postoperative lung function in patients with lung cancer: comparison of quantitative CT with perfusion scintigraphy. AJR Am J Roentgenol 2002;178:667-72. 10.2214/ajr.178.3.1780667
    1. Yoshimoto K, Nomori H, Mori T, et al. Prediction of pulmonary function after lung lobectomy by subsegments counting, computed tomography, single photon emission computed tomography and computed tomography: a comparative study. Eur J Cardiothorac Surg 2009;35:408-13. 10.1016/j.ejcts.2008.10.057
    1. Choe J, Lee SM, Chae EJ, et al. Evaluation of postoperative lung volume and perfusion changes by dual-energy computed tomography in patients with lung cancer. Eur J Radiol 2017;90:166-73. 10.1016/j.ejrad.2017.02.040
    1. Yoshimoto K, Nomori H, Mori T, et al. Quantification of the impact of segmentectomy on pulmonary function by perfusion single-photon-emission computed tomography and multidetector computed tomography. J Thorac Cardiovasc Surg 2009;137:1200-5. 10.1016/j.jtcvs.2008.10.028
    1. Yoshimoto K, Nomori H, Mori T, et al. A segmentectomy of the right upper lobe has an advantage over a right upper lobectomy regarding the preservation of the functional volume of the right middle lobe: analysis by perfusion single-photon emission computed tomography/computed tomography. Surg Today 2010;40:614-9. 10.1007/s00595-009-4103-9
    1. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365:1567-75. 10.1056/NEJMoa1106955
    1. Hogg JC, McDonough JE, Suzuki M. Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging. Chest 2013;143:1436-43. 10.1378/chest.12-1766
    1. Scott AE, Vasilescu DM, Seal KA, et al. Three dimensional imaging of paraffin embedded human lung tissue samples by micro-computed tomography. PLoS One 2015;10:e0126230. 10.1371/journal.pone.0126230
    1. Mai C, Verleden SE, McDonough JE, et al. Thin-Section CT Features of Idiopathic Pulmonary Fibrosis Correlated with Micro-CT and Histologic Analysis. Radiology 2017;283:252-63. 10.1148/radiol.2016152362
    1. Vasilescu DM, Phillion AB, Tanabe N, et al. Nondestructive cryomicro-CT imaging enables structural and molecular analysis of human lung tissue. J Appl Physiol (1985) 2017;122:161-9. 10.1152/japplphysiol.00838.2016
    1. Bommart S, Marin G, Bourdin A, et al. Relationship between CT air trapping criteria and lung function in small airway impairment quantification. BMC Pulm Med 2014;14:29. 10.1186/1471-2466-14-29
    1. Bommart S, Marin G, Bourdin A, et al. Computed tomography quantification of airway remodelling in normal ageing subjects: a cross-sectional study. Eur Respir J 2015;45:1167-70. 10.1183/09031936.00215314
    1. Bommart S, Kovacsik H, Vachier I, et al. Software-assisted Computed Tomography Quantification of Airway Remodeling in the Normal Aging Process. Am J Respir Crit Care Med 2017;195:540-1. 10.1164/rccm.201610-2028LE
    1. Coste F, Dournes G, Dromer C, et al. CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension. Thorax 2016;71:830-7. 10.1136/thoraxjnl-2015-207696
    1. Chae EJ, Kim N, Seo JB, et al. Prediction of postoperative lung function in patients undergoing lung resection: dual-energy perfusion computed tomography versus perfusion scintigraphy. Invest Radiol 2013;48:622-7. 10.1097/RLI.0b013e318289fa55
    1. Moons KG, Altman DG, Reitsma JB, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 2015;162:W1-73. 10.7326/M14-0698
    1. Moons KG, Altman DG, Reitsma JB, et al. New Guideline for the Reporting of Studies Developing, Validating, or Updating a Multivariable Clinical Prediction Model: The TRIPOD Statement. Adv Anat Pathol 2015;22:303-5. 10.1097/PAP.0000000000000072
    1. Juhl B, Frost N. A comparison between measured and calculated changes in the lung function after operation for pulmonary cancer. Acta Anaesthesiol Scand Suppl 1975;57:39-45. 10.1111/j.1399-6576.1975.tb05411.x
    1. British Thoracic Society. Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party . BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001;56:89-108. 10.1136/thorax.56.2.89
    1. Seely AJ, Ivanovic J, Threader J, et al. Systematic classification of morbidity and mortality after thoracic surgery. Ann Thorac Surg 2010;90:936-42; discussion 942. 10.1016/j.athoracsur.2010.05.014
    1. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40:1324-43. 10.1183/09031936.00080312
    1. Graham BL, Brusasco V, Burgos F, et al. 2017. ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J 2017;49:1600016 Erratum in: Eur Respir J 2018;52.
    1. American Thoracic Society. American College of Chest Physicians . ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167:211-77. 10.1164/rccm.167.2.211
    1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories . ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7. 10.1164/ajrccm.166.1.at1102
    1. Gevenois PA, de Maertelaer V, De Vuyst P, et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995;152:653-7. 10.1164/ajrccm.152.2.7633722
    1. Mariano-Goulart D, Barbotte E, Basurko C, et al. Accuracy and precision of perfusion lung scintigraphy versus 133Xe-radiospirometry for preoperative pulmonary functional assessment of patients with lung cancer. Eur J Nucl Med Mol Imaging 2006;33:1048-54. 10.1007/s00259-006-0087-5
    1. Parker JA, Coleman RE, Grady E, et al. SNM practice guideline for lung scintigraphy 4.0. J Nucl Med Technol 2012;40:57-65. 10.2967/jnmt.111.101386
    1. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727-36. 10.1007/s11136-011-9903-x
    1. Schwenkglenks M, Matter-Walstra K. Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments. Expert Rev Pharmacoecon Outcomes Res 2016;16:207-19. 10.1586/14737167.2016.1146594
    1. Giesinger JM, Kieffer JM, Fayers PM, et al. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol 2016;69:79-88. 10.1016/j.jclinepi.2015.08.007
    1. Sprangers MA, Cull A, Groenvold M, et al. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group. Qual Life Res 1998;7:291-300. 10.1023/A:1008890401133
    1. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76. 10.1093/jnci/85.5.365
    1. Osoba D, Zee B, Pater J, et al. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 1994;3:353-64. 10.1007/BF00451727
    1. Bergman B, Aaronson NK, Ahmedzai S, et al. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 1994;30A:635-42. 10.1016/0959-8049(94)90535-5
    1. Koller M, Warncke S, Hjermstad MJ, et al. Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development. Cancer 2015;121:4300-23. 10.1002/cncr.29682
    1. Fayers PM, Aaronson NK, Bjordal K, et al. EORTC QLQ-C30 scoring manual. Eortc 1999.
    1. R Core Team. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing 2016. Available online:
    1. Bezanson J, Edelman A, Karpinski S, et al. Julia: A fresh approach to numerical computing. SIAM Review 2017;59:65-98. 10.1137/141000671

Source: PubMed

3
Abonneren